ArticleFrontiers in oncology2019

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac.

Jesús A Junco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.